menu
    • menu

    Company profile for Dynavax Technologies

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dynavax Technologies Corporation (Nasdaq: DVAX) is a fully-integrated biopharmaceutical company focused on leveraging the power of the body’s innate and adaptive immune responses through Toll-like Receptor (TLR) stimulation. Dynavax develops, and commercializes novel vaccines. We are committed to a rigorous approach to drug development in the field of TLR biology so that we may help physicians and patients address unmet n...
    Dynavax Technologies Corporation (Nasdaq: DVAX) is a fully-integrated biopharmaceutical company focused on leveraging the power of the body’s innate and adaptive immune responses through Toll-like Receptor (TLR) stimulation. Dynavax develops, and commercializes novel vaccines. We are committed to a rigorous approach to drug development in the field of TLR biology so that we may help physicians and patients address unmet needs. Our vision and work ethic are guided by the collective ideals underpinning our corporate values, and these form the basis of our company culture.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Dynavax TechnologiesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2100 Powell Street, Suite 900 Emeryville, CA 94608
    Telephone
    Telephone
    +1.510.848.5100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.dynavax.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dynavax To Present At Evercore Healthcare Conference
    Dynavax To Present At Evercore Healthcare Conference

    20 Nov 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/dynavax-to-participate-at-the-8th-annual-evercore-healthcare-conference-302620786.html

    PR NEWSWIRE BIO
    20 Nov 2025
    Share Share
    Dynavax Unveils Q3 2025 Financials, Launches $100M Share Buyback
    Dynavax Unveils Q3 2025 Financials, Launches $100M Share Buyback

    05 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dynavax-reports-third-quarter-2025-financial-results-and-announces-new-100-million-share-repurchase-program-302606025.html

    PR NEWSWIRE
    05 Nov 2025
    Share Share
    Dynavax Enters License Agreement for Vaxart's Oral COVID Vaccine
    Dynavax Enters License Agreement for Vaxart's Oral COVID Vaccine

    05 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dynavax-enters-exclusive-license-agreement-for-vaxarts-novel-oral-covid-19-vaccine-program-302606056.html

    PR NEWSWIRE
    05 Nov 2025
    Share Share
    Dynavax Reveals Phase 1/2 Shingles Vaccine Trial Results
    Dynavax Reveals Phase 1/2 Shingles Vaccine Trial Results

    22 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dynavax-presents-positive-topline-data-from-part-1-of-phase-12-trial-for-shingles-vaccine-candidate-at-idweek-2025-and-announces-initiation-of-part-2-of-trial-302590508.html

    PR NEWSWIRE
    22 Oct 2025
    Share Share
    Dynavax To Present Q3 2025 Financial Results And Host Conference
    Dynavax To Present Q3 2025 Financial Results And Host Conference

    22 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dynavax-to-report-third-quarter-2025-financial-results-and-host-conference-call-on-november-5-2025-302591183.html

    PR NEWSWIRE
    22 Oct 2025
    Share Share
    Dynavax to Attend 2025 Wells Fargo Healthcare Conference
    Dynavax to Attend 2025 Wells Fargo Healthcare Conference

    27 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dynavax-to-participate-in-the-2025-wells-fargo-healthcare-conference-302540380.html

    PR NEWSWIRE
    27 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search